Latest News about JNJ
Recent news which mentions JNJ
From Benzinga
5 Top Dividend Stocks Investors Should Never Sell
November 09, 2022
From Motley Fool
From Benzinga
The 7 Best Pharma Stocks to Buy Now
November 08, 2022
From InvestorPlace
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
November 08, 2022
From Motley Fool
3 No-Brainer Stocks to Buy in a Downturn
November 08, 2022
From Motley Fool
2 Powerhouse Dividend Stocks to Invest in This Month
November 08, 2022
From Motley Fool
US Authority Plans Massive Expansion Of Medication Access To Combat Opioid Overdose Crisis
November 08, 2022
From Benzinga
Cramer On This Stock Up 138% Year-To-Date: 'Santa Can't Afford That Coal, It's Going Up Too Much'
November 07, 2022
From Benzinga
Johnson & Johnson's Big Purchase, Amazon's New Moves, and More
November 05, 2022
From Motley Fool
3 No-Brainer Dividend Stocks to Buy in November
November 05, 2022
From Motley Fool
Is Johnson & Johnson's Purchase of Abiomed Good for Investors?
November 05, 2022
From Motley Fool
Beat the Dow Jones With This Unstoppable Dividend Stock
November 05, 2022
From Motley Fool
A $10,000 Investment at the Start of the Great Recession Would Be Worth This Much Today
November 04, 2022
From Motley Fool
Why Is Provention Biosciences (PRVB) Stock Up 25% Today?
November 03, 2022
From InvestorPlace
Cramer's Take On This Stock That's Down 53% Year-To-Date: 'I Think Long-Term. I Don't Want To Own It'
November 03, 2022
From Benzinga
2 Compelling Stocks to Buy in a Bear Market
November 03, 2022
From Motley Fool
Is Johnson & Johnson an Underrated Growth Stock?
November 02, 2022
From Motley Fool
Hurry! 7 Pitiful Nasdaq Stocks to Sell Before 2022 Ends.
November 01, 2022
From InvestorPlace
Why Abiomed Stock Skyrocketed Today
November 01, 2022
From Motley Fool
What To Watch In The S&P Biotech ETF After Johnson & Johnson's $16.6B Abiomed Deal
November 01, 2022
From Benzinga
10 Best Stocks to Buy Now in November
November 01, 2022
From Motley Fool
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
From Benzinga
Poseidon’s $10.9 billion take-private deal for Atlas Corp. sets sail at sweetened price
November 01, 2022
From MarketWatch
Why Is Abiomed (ABMD) Stock Up 50% Today?
November 01, 2022
From InvestorPlace
Johnson & Johnson Expands Cardiovascular Portfolio, Bets $16B In Abiomed's Heart Failure Devices
November 01, 2022
From Benzinga
Uber Rides Higher, but Here's Tuesday's Big Stock Winner
November 01, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.